Trade name: Xiclav 250 mg
Active substance: acid clavulanic, amoxicilină trihidrat
Therapeutic group: Antibiotics
Pharmaceutical form: comprimate filmate
Presentation: blister x 8 cpr.
Trade name: Xiclav 250 mg
Active substance: acid clavulanic, amoxicilină trihidrat
Therapeutic group: Antibiotics
Pharmaceutical form: comprimate filmate
Presentation: blister x 8 cpr.
Target species: dogs, cats
Therapeutic action: Caini si pisici Tratamentul infectiilor determinate de microorganisme sensibile la acțiunea substanțelor active.
Waiting period: Nu este cazul.
Release mode: Cu prescripţie
Authorization number: 160256
Authorization status: Retrasa
Date of issue of the authorization: 17-08-2016
Authorization valid until: nelimitata
Manufacturer / Serial Release Company: LEK PHARMACEUTICALS d.d., Slovenia
Licensee: NOVARTIS ANIMAL HEALTH d.o.o., Slovenia
Responsible company in Romania: BIOMEDIAL REGULATORY SRL
Remarks: Autorizatie de Comercializare retrasă din 13.04.2017, la solicitarea deținătorului autorizatiei de comercializare.